Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges about a scheduled one-on-one meeting with Sundaram Asset Management on March 16, 2026. The filing is made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30) to keep the market informed of investor interactions. The company has noted that the schedule is subject to change due to last-minute exigencies. This is a routine disclosure and does not indicate any material corporate action.
This is a standard regulatory disclosure and typically has no direct impact on the stock price. It signals continued institutional engagement but investors should wait for any material information that may emerge from the meeting.